Reduced Inflammation Research suggests GLP-1 receptor agonists may lower signs of chronic, low-grade inflammation, including markers like C-reactive protein, and may also improve oxidative stress in the body
Research demonstrates that butyrate supports insulin sensitivity -- helping cells respond to insulin and take up glucose efficiently
Blood markers confirm this: patients in rapid weight loss phases show decreased glutathione-to-GSSG ratios (the oxidised form), indicating depletion
Regarding Fe, Cd 2 is predominantly absorbed through non-specific transporters of the Iron-Regulated Transporter ( IRT ) family, particularly IRT1 , which mediates the uptake of multiple divalent metals into roots
There is no direct equivalent chart of GLP-1 medications
The trade-off is a broader side effect profile caused by non-selective receptor activation